Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Inspire Medical Systems (INSP) PT Lowered to $220 at Morgan Stanley
February 11, 2025 7:09 AM ESTMorgan Stanley analyst Kallum Titchmarsh lowered the price target on Inspire Medical Systems (NYSE: INSP) to $220.00 (from $230.00) while maintaining a Overweight rating.
The analyst comments "A good way for INSP to close out the year with profitability coming in comfortably ahead. Both existing... More
Inspire Medical Systems (INSP) PT Raised to $194 at Leerink Partners
February 11, 2025 6:32 AM ESTLeerink Partners analyst Mike Kratky raised the price target on Inspire Medical Systems (NYSE: INSP) to $194.00 (from $193.00) while maintaining a Market Perform rating.
The analyst comments "Bottom Line: We are bumping up our price target on INSP to $194 (from $193) to reflect our updated model and slightly lower share count following the company's 4Q24 earnings. However, we are... More



